News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ImmuneRegen BioSciences, Inc. (IRBO) to Provide Adjuvant to DynPort Vaccine Company LLC for Development of an Inactivated Vaccine against Venezuelan Equine Encephalitis Virus


4/30/2008 9:23:48 AM

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--ImmuneRegen BioSciences, a wholly owned subsidiary of IR BioSciences Holdings, Inc. (OTCBB: IRBO), will provide its adjuvant candidate, Viprovex®, for nonclinical studies of a Venezuelan equine encephalitis vaccine developed at DynPort Vaccine Company LLC (DVC), a Computer Sciences Corporation (NYSE: CSC) company.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES